Delivery Order SPE2DB22D3009-SPE2DB24FAP84

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $3.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,828.64 and a completion date of March 13, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,847.29 and is a firm fixed-price delivery order with a completion date of November 20, 2023. The award was made on November 17, 2023, and there was no set-aside used. Amerisourcebergen Drug Corp is...
The federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $11,402.09. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of Vivitrol 380 mg vials and diluents to the Defense Logistics Agency (DLA). The $1,685.66 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 31, 2022, with a completion date of February 1, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The federal contract award is for the delivery of Vivitrol 380 mg vials and diluents to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the provision of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,828.64 and a completion date of July 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $3,147.87. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $15,018.36 and is a firm-fixed-price delivery order with a completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,218.97 and a completion date of May 30, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FAP84
    Delivery Order

This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,389.32 and is a delivery order with a firm fixed price. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/14/25, 10:21 AM